ERBB2 activating variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | ERBB2 activating variants | Non-Small Cell Lung Cancer | Trastuzumab deruxtecan |